Siemens Healthcare has released several new systems into the PET-CT and SPECT-CT markets. The new systems are expected to enable facilities with limited budgets, or those under financial constraints, to provide molecular imaging technology to their patients.
The company has also announced the launch of the Biograph mCT that reportedly enables facilities to serve both the nuclear medicine and the radiology department with one system through the integration of PET and CT technologies.
Biograph TruePoint 16-slice PET-CT is another addition to the Biograph family of clinical scanners. Reportedly, this imaging system can perform HD-PET and routine as well as 10-minute whole-body imaging.
Besides, new releases in system applications include a thin-client application for SPECT systems, Symbia.net. The Symbia family of SPECT and SPECT-CT scanners are expected to meet various needs of imaging facility. The company states that its new Symbia E, and Symbia S and T are suited for facilities that currently do not offer molecular imaging or for facilities with a limited budget.
Michael Reitermann, chief executive officer of molecular imaging at Siemens Healthcare, said: Though we’ve recently made some progress in US imaging reimbursement policies, we need to further develop evidence-based data on a global level, so that we can continue to prove the clinical and financial efficacy of molecular imaging technology as a valuable asset to detect, stage and monitor disease.
